Streetbeat News

Earnings

HLNE

Hamilton Lane (NASDAQ:HLNE) reported Q3 adjusted earnings of $0.71 per share, missing the consensus estimate of $0.92 by 22.83%. Year-over-year, earnings increased by 65.12% from $0.43 per share. Quarterly sales were $125.26M, missing the consensus estimate of $130.47M by 3.99%, and representing a 1.42% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 12:05 pm

ENR

Energizer Holdings has provided guidance for its Q2 adjusted EPS to be in the range of $0.65-$0.70, which is below the analyst estimate of $0.71. Additionally, the company expects its organic revenue to decrease by 2%-3%.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 12:05 pm

KKR

KKR & Co (NYSE:KKR) reported Q4 adjusted earnings of $1.00 per share, surpassing the $0.93 estimate, and sales of $1.63B, exceeding the $1.60B estimate. This represents an 8.7% increase in earnings and a 9.99% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 12:05 pm

CRNC

Cerence Inc (CRNC) provided its Q2 and FY24 revenue forecasts, expecting Q2 revenue of $60M-$64M, below the $70.87M estimate, and FY24 revenue of $355M-$375M, slightly below the $362.14M estimate. The company anticipates a GAAP Net Loss for Q2 but expects positive GAAP Net Income and Adjusted EBITDA for the full year.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 12:05 pm

FISV

Fiserv has projected its 2024 organic revenue growth to be between 15%-17% and expects its adjusted EPS to range from $8.55 to $8.70, aligning closely with the estimated $8.61.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 12:04 pm

FISV

Fiserv reported its Q4 adjusted earnings per share at $2.19, surpassing the consensus estimate of $2.15 by 1.86%. This represents a 14.66% increase from the $1.91 per share reported in the same quarter last year.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 12:03 pm

CRNC

Cerence (NASDAQ:CRNC) reported Q1 adjusted EPS of $1.12, surpassing the $0.90 estimate, marking a 211.11% increase from last year. Sales reached $138.34M, exceeding the $131.13M estimate, up 65.36% from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 12:02 pm

TW

Tradeweb reported a significant increase in its average daily volume for Q4, reaching $1.7 trillion, which represents a 56.9% increase compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 12:02 pm

DCPH

Deciphera Pharmaceuticals (NASDAQ:DCPH) reported Q4 earnings with EPS of $(0.54), surpassing the $(0.58) estimate, and sales of $48.30M, exceeding the $45.92M estimate. This represents a 10% improvement in EPS and a 32.88% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 12:01 pm

XYL

Xylem projects its FY24 adjusted EPS to be in the range of $4.00-$4.20, compared to the estimated $4.07. The company also forecasts sales to be between $8.4B-$8.5B, aligning closely with the estimated $8.42B.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 12:01 pm